CHRO: Utang jangka cendhak perusahaan Chromocell Therapeutics Corp.
Chromocell Therapeutics (CHRO) is developing an opioid-free pain management system by innovating the function of sodium channels. As reflected in the pakistan chart, the asset value on GURU.Markets is 0.00. Business development relies on synergy with clinical centers, while the success of primary trials enables the company to retain top-tier scientists and attract leading medical executives.
Rincian analitis perusahaan Chromocell (CHRO)
- kuotasi saiki lan rata-rata prakiraan nilai:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- rincian utang lan likuiditas:
Utang marang Ekuitas Chromocell Therapeutics|CHRO - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Chromocell Therapeutics|CHRO - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Chromocell Therapeutics Corp.|CHRO - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Chromocell Therapeutics|Rasio cepet chromocell.com
- indikator pendapatan resik lan kelipatan nilai:
Analisis dhasar perusahaan:CHRO - Chromocell Therapeutics Corp.
Chromocell Therapeutics (CHRO) invests in the development of non-opioid analgesics, meaning an analysis of its short-term debt portfolio allows for an assessment of the company's liquidity during a period of intensive R&D spending. This indicator aggregates all liabilities with a maturity of up to one year, where rising debt signals a risk of capital shortage, while its reduction confirms the asset's financial stability ahead of the official earnings release.
Analisis pesaing
BIIB - Utang jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan NBIX (Neurocrine)|Regencell (RGC) - Utang jangka cendhak perusahaan|Utang jangka cendhak Axsome Corp (AXSM)|ACAD (ACADIA Pharmaceuticals) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan xenon-pharma.com (XENE)|Utang jangka cendhak perusahaan VKTX|SUPN (Supernus Pharmaceuticals, Inc.) - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Catalyst Pharmaceuticals Inc CPRX|Silihan lan utang jangka cendhak perusahaan DNLI|HRMY - Utang jangka cendhak perusahaan|Utang jangka cendhak biohavenpharma.com|Amylyx Pharmaceuticals, Inc. (AMLX) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan Trevi Therapeutics Inc|Utang jangka cendhak perusahaan Praxis Medicines|Utang jangka cendhak Anavex Life Sciences Corp AVXL|Utang jangka cendhak perusahaan CBLL|Kewajiban jangka cendhak perusahaan Prothena Corporation plc PRTA|Utang jangka cendhak perusahaan ALEC (Alector)|Annexon Biosciences (ANNX) - Utang jangka cendhak|OMER - Utang jangka cendhak perusahaan|NGNE: Utang jangka cendhak perusahaan|AC Immune (ACIU) - Utang jangka cendhak perusahaan|VYGR (voyagertherapeutics.com) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan NMRA|SCLX: Silihan lan utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan TVGN (Tevogen Bio Holdings, Inc.)|Gedhene kewajiban jangka cendhak ACOG|Utang jangka cendhak perusahaan CGTX (Cognition Therapeutics, Inc.)|Silihan lan utang jangka cendhak perusahaan IKT|Cassava Sciences - Utang jangka cendhak perusahaan|Utang jangka cendhak Assertio Holdings, Inc.|coyatherapeutics.com (COYA) - Utang jangka cendhak perusahaan|Vistagen - Silihan lan utang jangka cendhak perusahaan|OVID (Ovid Therapeutics Inc) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan acumenpharm.com|Utang jangka cendhak perusahaan CervoMed (CRVO)|ATHE: Kewajiban jangka cendhak|Utang jangka cendhak perusahaan CLNN (Clene)|PepGen Inc (PEPG) - Utang jangka cendhak|JUNS: Kewajiban jangka cendhak perusahaan|RLMD - Utang jangka cendhak perusahaan|ANVS (Annovis Bio) - Kewajiban jangka cendhak perusahaan|GRCE: Gedhene kewajiban jangka cendhak|AIFF (Firefly Neuroscience Inc) - Utang jangka cendhak perusahaan|ANEW Medical, Inc. (KLTO) - Gunggunge utang jangka cendhak|Utang jangka cendhak perusahaan NRSN|Kewajiban jangka cendhak perusahaan revivapharma.com RVPH|Utang jangka cendhak perusahaan MetaVia MTVA|Gunggunge utang jangka cendhak NeurAxis Inc. (NRXS)|Helius Medical Technologies Inc. - Utang jangka cendhak perusahaan|Passage Bio, Inc. (PASG) - Kewajiban jangka cendhak perusahaan|NEUP: Utang jangka cendhak perusahaan|minervaneurosciences.com - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Athira Pharma|ADXN: Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Alzamend Neuro, Inc. (ALZN)|CYCN - Utang jangka cendhak|Utang jangka cendhak perusahaan Protagenic Therapeutics, Inc. PTIX|KTTA: Tanggungan utang jangka cendhak perusahaan|Cortigent Medical - Utang jangka cendhak perusahaan|Utang jangka cendhak Avenue Therapeutics Inc.|BCLI (Brainstorm Cell Therapeutics, Inc.) - Kewajiban jangka cendhak perusahaan|Cara Therapeutics Inc (CARA) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Eliem Therapeutics, Inc.|ITCI: Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Longboard Pharmaceuticals, Inc. (LBPH)|MRNS - Utang jangka cendhak|Utang jangka cendhak perusahaan NKGN (NKGen)|NRBO - Kewajiban jangka cendhak perusahaan|Sage Therapeutics, Inc. - Utang jangka cendhak perusahaan|Silihan lan utang jangka cendhak perusahaan SNPX (synaptogen.com)|Trevena (TRVN) - Utang jangka cendhak perusahaan|Vigil Neuroscience, Inc. - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Anew Medical, Inc.|Utang jangka cendhak Cerevel Corp CERE